In vitro biocompatibility performance of Physioneal.
D000818:Animals; D001639:Bicarbonates / Q000008:administration & dosage; D001672:Biocompatible Materials / Q000737:chemistry / Q000494:pharmacology / Q000592:standards*; D015314:Dialysis Solutions / Q000737:chemistry / Q000494:pharmacology / Q000592:standards*; D004847:Epithelial Cells / Q000187:drug effects; D005347:Fibroblasts / Q000187:drug effects; D005947:Glucose / Q000008:administration & dosage / Q000378:metabolism; D017127:Glycation End Products, Advanced / Q000096:biosynthesis; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007773:Lactates / Q000008:administration & dosage; D007962:Leukocytes / Q000187:drug effects; D008422:Materials Testing / Q000592:standards; D009930:Organic Chemicals; D010537:Peritoneum / Q000166:cytology / Q000187:drug effects; D011237:Predictive Value of Tests
D001639:Bicarbonates; D001672:Biocompatible Materials; D015314:Dialysis Solutions; D017127:Glycation End Products, Advanced; D007773:Lactates; D009930:Organic Chemicals; C488051:Physioneal 40; D005947:Glucose